[1] |
Hirano T.Pathophysiology of diabetic dyslipidemia [J].J Atheroscler Thromb, 2018, 25(9): 771-782.
|
[2] |
Viktorinova A, Malickova D, Svitekova K, et al.Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes [J].Diabetes Res Clin Pract, 2021,176: 108858.
|
[3] |
Grundy SM.Small LDL, atherogenic dyslipidemia, and the metabolic syndrome [J].Circulation,1997, 95(1): 1-4.
|
[4] |
Dobiásová M, Frohlich J.The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL))[J].Clin Biochem, 2001, 34(7): 583-588.
|
[5] |
Dobiásová M.AIP—atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice [J].Vnitr Lek, 2006, 52(1): 64-71.Czech.
|
[6] |
Nosrati M, Safari M, Alizadeh A, et al.The atherogenic index log(triglyceride/HDL-Cholesterol) as a biomarker to identify type 2 diabetes patients with poor glycemic control [J].Int J Prev Med, 2021,12: 160.
|
[7] |
Fernández-Macías JC, Ochoa-Martínez AC, Varela-Silva JA, et al.Atherogenic index of plasma: novel predictive biomarker for cardiovascular illnesses [J].Arch Med Res, 2019, 50(5): 285-294.
|
[8] |
Chen M, Fang CY, Guo JC, et al.Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction [J].Front Cardiovasc Med, 2023, 26, 10: 1117362.
|
[9] |
Reyes-Ferrada W, Solis-Urra P, Plaza-Díaz J, et al.Cardiorespiratory fitness, physical activity, sedentary time and its association with the atherogenic index of plasma in chilean adults: influence of the waist circumference to height ratio [J].Nutrients, 2020, 28, 12(5): 1250.
|
[10] |
Pansuria M, Xi H, Li L, et al.Insulin resistance, metabolic stress, and atherosclerosis [J].Front Biosci (Schol Ed), 2012, 4(3): 916-931.
|
[11] |
中华医学会糖尿病学分会胰岛素抵抗血组.胰岛素抵抗评估方法和应用的专家指导意见 [J].中华糖尿病杂志, 2018, 10(6): 377-385.
|
[12] |
吴晓明, 周玉, 郭俊, 等.2型糖尿病患者C肽胰岛素抵抗指数和VLDL-C与致动脉粥样硬化指数的相关性 [J].中国医师杂志,2021, 23(7): 982-986, 991.
|
[13] |
Ko SH, Jung Y.Energy metabolism changes and dysregulated lipid metabolism in postmenopausal women [J].Nutrients, 2021, 13(12):4556.
|
[14] |
Alemany M.Estrogens and the regulation of glucose metabolism [J].World J Diabetes, 2021,12(10): 1622-1654.
|
[15] |
Wu TT, Gao Y, Zheng YY, et al.Atherogenic index of plasma(AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women [J].Lipids Health Dis, 2018, 17(1): 197.
|
[16] |
Zhang JS, Yeh WC, Tsai YW, et al.The relationship between atherogenic index of plasma and obesity among adults in Taiwan [J].Int J Environ Res Public Health, 2022, 11, 19(22): 14864.
|
[17] |
Cho Y, Lee SY.Useful biomarkers of metabolic syndrome [J].Int J Environ Res Public Health, 2022, 15, 19(22): 15003.
|
[18] |
Parveen S, Khan S, Khan MM, et al.Association of lipid profile and obesity in patients with polycystic ovary syndrome [J].Endocr Regul,2024, 24, 58(1): 83-90.
|
[19] |
Bajaj S, Prajapati SK.Atherosclerosis and associated cardiovascular risk factors in nonalcoholic fatty liver disease and metabolic syndrome[J].J Assoc Physicians India, 2022, 70(6): 11-12.
|
[20] |
Nascimento GM, Longo GZ, Valmorbida A, et al.Prevalence of body composition phenotypes and their associations with glycemic, lipidic,and inflammatory biomarkers: a population-based study [J].Cad Saude Publica, 2024, 14, 40(5): e00109823.
|
[21] |
YBlaak EE, Goossens GH.Metabolic phenotyping in people living with obesity: Implications for dietary prevention [J].Rev Endocr Metab Disord, 2023, 24(5): 825-838.
|
[22] |
Ndumele CE, Rangaswami J, Chow SL, et al.Cardiovascular-Kidney-Metabolic Health: a presidential advisory from the American Heart Association [J].Circulation.2023, 148(20):1606-1635.
|
[23] |
Nur Zati Iwani AK, Jalaludin MY, Yahya A, et al.TG: HDL-C ratio as insulin resistance marker for metabolic syndrome in children with obesity [J].Front Endocrinol (Lausanne), 2022, 10, 13: 852290.
|
[24] |
Babic N, Valjevac A, Zaciragic A, et al.The triglyceride/HDL ratio and triglyceride glucose index as predictors of glycemic control in patients with diabetes mellitus type 2 [J].Med Arch, 2019, 73(3): 163-168.
|
[25] |
吴晓明, 赵伟, 刘佳, 等.男性2型糖尿病患者血浆致动脉粥样硬化指数相关危险因素研究 [J].中华内分泌代谢杂志, 2012, 28(9):720-722.
|
[26] |
Bhatt MP, Lim YC, Kim YM, et al.C-peptide activates AMPKα and prevents ROS-mediated mitochondrial fission and endothelial apoptosis in diabetes [J].Diabetes, 2013, 62(11): 3851-3862.
|
[27] |
Chen J, Huang Y, Liu C, et al.The role of C-peptide in diabetes and its complications: an updated review [J].Front Endocrinol (Lausanne),2023, 14: 1256093.
|
[28] |
王鑫, 李志红, 尹飞, 等.糖尿病患者C肽与动脉粥样硬化关系的研究进展 [J].医学综述, 2018(17): 3452-3456.
|
[29] |
Wahab MA, Alhabibi AM, Sakr AK, et al.The correlation between C-Peptide and severity of peripheral atherosclerosis in type 2 diabetes mellitus [J].Diabetes Metab Syndr Obes, 2023, 16: 2617-2625.
|
[30] |
Katz A, Nambi SS, Mather K, et al.Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans [J].J Clin Endocrinol Metab, 2000, 85(7): 2402-2410.
|
[31] |
Alissa EM, Algarni SA, Khaffji AJ, et al.Role of inflammatory markers in polycystic ovaries syndrome: in relation to insulin resistance [J].J Obstet Gynaecol Res, 2021, 47(4): 1409-1415.
|
[32] |
Krawczyk M, Rumińska M, Witkowska-Sędek E, et al.Usefulness of the triglycerides to high-density lipoprotein cholesterol ratio (TG/HDL-C) in prediction of metabolic syndrome in Polish obese children and adolescents [J].Acta Biochim Pol, 2018, 65(4): 605-611.
|
[33] |
Brehm A, Pfeiler G, Pacini G, et al.Relationship between serum lipoprotein ratios and insulin resistance in obesity [J].Clin Chem,2004, 50(12): 2316-22.
|